Ovidrel Solution For Injection 250Mcg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Ovidrel: Solution for injection (250mcg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_6200.JPG
Ovidrel 250mcg/0.5ml for Inj
EMD Serono Inc

What is this Medicine?

HUMAN CHORIONIC GONADOTROPIN (HYOO muhn kor ee ON ik goe NAD oh troe pin) is a hormone. HCG is used for different reasons in men and women. HCG is used in combination with other fertility drugs to increase a woman's chance of pregnancy. In men or adolescent boys, HCG helps the production of testosterone and sperm. HCG is also used in male children with cryptorchidism, a specific birth problem of the testes.

CVS Pharmacy Patient Statistics for Ovidrel: Solution for injection(250mcg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Ovidrel 250mcg/0.5ml Pre-Filled Syringe for Injection

NDC: 440871150
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Infertility

Sometimes used for but not FDA approved for the following conditions:
Kaposi's Sarcoma

Storage Information
After dispensing, refrigeration is recommended but not required if product is stored below 77 degrees F and used within 30 days
Protect from light
Store in original container
Discard unused portion. Do not store for later use.
Prior to dispensing, store in refrigerator (36 to 46 degrees F)
Ovidrel 250mcg/0.5ml Pre-Filled Syringe for Injection
Drug Image file DrugItem_6200.JPG
EMD Serono Inc
Pill Identification:
Shape: not applicable
Color: colorless

Reported Side Effects for Ovidrel 250mcg/0.5ml Pre-Filled Syringe for Injection

Skin Rash Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Feeling Sick Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Vaginal Discharge Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Gynecomastia Incidence:
<30.0%*
Severity: MILD
Onset: DELAYED
Emotional Lability Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Breakthrough Bleeding Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Back Pain Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Vaginal Bleeding Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Tubal Pregnancy Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Gas Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Hot Flashes Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Inability To Sleep Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Breast Pain Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Itching Incidence:
<2.0%*
Severity: MILD
Onset: RAPID
Vaginal Infection Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Ovarian Hyperstimulation Syndrome (OHSS) Incidence:
1.7-9.0%*
Severity: SEVERE
Onset: DELAYED
Vomiting Incidence:
2.5%*
Severity: MILD
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
3.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Enlarged Ovaries Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
3.0-4.2%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
3.4%*
Severity: MILD
Onset: EARLY
Injection Site Reaction Incidence:
14.0-16.2%*
Severity: MILD
Onset: RAPID
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

SECOND Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

THIRD Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Ovidrel

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5